The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalworth Regulatory News (GWI)

Share Price Information for Globalworth (GWI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.41
Bid: 2.36
Ask: 2.46
Change: 0.00 (0.00%)
Spread: 0.10 (4.237%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.41
GWI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exchange Offer Final Settlement

26 Apr 2024 07:00

RNS Number : 1238M
Globalworth Real Estate Inv Ltd
26 April 2024
 

26 April 2024

 

This announcement shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities referred to herein in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any such jurisdiction.

 

Globalworth Real Estate Investments Limited

("Globalworth" or the "Company")

 

Exchange Offer Final Settlement Announcement

Capitalised terms used in this announcement, but not defined, have the meanings given to them in the Company's announcement on 28 March 2024.

 

Further to its announcements on 28 March 2024, 10 April 2024 and 22 April 2024, Globalworth is pleased to announce the successful refinancing of its €550,000,000 2025 Notes due in March 2025, of which €450,000,000 were outstanding, and €400,000,000 2026 Notes due in July 2026, of which €400,000,000 were outstanding (collectively, the "Existing Notes"), with 6.25% Notes due in March 2029 for an amount of €307,109,200 and 6.25% Notes due in March 2030 for an amount of €333,350,400 (collectively, the "New Notes"), respectively (the "Refinancing"). The Refinancing was concluded by means of the Exchange Offer and Consent Solicitation, pursuant to which all holders of Existing Notes received New Notes and the holders tendering by the Early Exchange Deadline the cash consideration, in each case as applicable.

 

The New Notes were issued as Green Bonds and are intended to be used to finance or refinance Eligible Green Projects pursuant to the Company's Green Financing Framework available at https://www.globalworth.com/investor-relations/bonds.

 

The Refinancing will result in significant benefits for Globalworth including an improved debt maturity profile, by introducing maturities in 2029 and 2030 for the New Notes, respectively, and cancellation in full of the Existing Notes, which in turn will provide significant flexibility to execute our strategy, and affirmation of the Company's credit rating at BB+ and BBB- by S&P and Fitch respectively following announcement of the Refinancing. *

 

Dennis Selinas, Chief Executive Officer of Globalworth commented, "I am very pleased to announce that we have successfully completed our Refinancing, showcasing strong support for the Company from both the 2025 Notes and 2026 Notes holders, who participated at levels above 84% and 86%, respectively, in the Exchange Offer. We believe these high levels of participation are a testament to their confidence in the team, strategy, portfolio, and growth trajectory of the Company. Our new capital structure provides us with financial stability and allows us to focus on our existing portfolio as well as future investment activity to drive shareholder value. We thank all of our stakeholders for their commitment to our continued future success.'

Advisors

Perella Weinberg UK Limited acted as financial advisor to the Company. Merrill Lynch International acted as Lead Dealer Manager and Green Structuring Coordinator, Erste Group Bank AG and Raiffeisen Bank International AG acted as Co-Dealer Managers and Kroll Issuer Services Limited as Exchange and Tabulation Agent in connection with the Exchange Offer and the Consent Solicitation. Milbank LLP acted as international legal counsel to the Company. Latham & Watkins LLP acted as international legal counsel to the Lead Dealer Manager and the Co-Dealer Managers.

 

 

For further information, visit www.globalworth.com or contact:

 

Enquiries 

 

Rashid Mukhtar

Group CFO

 

Tel: +40 732 800 000

Panmure Gordon (Nominated Adviser and Joint Broker)

Dominic Morley 

Tel: +44 20 7886 2500

 

About Globalworth / Note to Editors: 

 

Globalworth is a listed real estate company active in Central and Eastern Europe, quoted on the AIM-segment of the London Stock Exchange. It has become the pre-eminent office investor in the CEE real estate market through its market-leading positions both in Poland and Romania. Globalworth acquires, develops and directly manages high-quality office and industrial real estate assets in prime locations, generating rental income from high quality tenants from around the globe. Managed by over 269 professionals across Cyprus, Guernsey, Poland and Romania the combined value of its portfolio is €3.0 billion, as at 31 December 2023. Approximately 96.8% of the portfolio is in income-producing assets, predominately in the office sector, and leased to a diversified array of over 715 national and multinational corporates. In Poland Globalworth is present in Warsaw, Wroclaw, Lodz, Krakow, Gdansk and Katowice, while in Romania it has assets in Bucharest and seven other cities.

For more information, please visit www.globalworth.com and follow us on Facebook, Instagram and LinkedIn.

IMPORTANT NOTICE:

 

This announcement does not constitute, or form part of, an offer or invitation to sell or issue, or any solicitation of an offer to buy or subscribe for, any securities in the United States or any other jurisdiction nor shall it (or any part of this announcement) or the fact of its distribution form the basis of, or be relied upon in connection with, or act as any inducement to enter into, any contract or commitment. Recipients of this announcement who intend to purchase any securities are reminded that any such purchase or subscription must be made solely on the basis of the information contained in any final form offering circular published in connection with any such securities. In certain jurisdictions, the transactions described above and the distribution of this announcement and other information in connection with the transactions described above may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

* A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or

withdrawal at any time. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURUVOURSNUSUUR
Date   Source Headline
26th Apr 20247:00 amRNSExchange Offer Final Settlement
22nd Apr 20244:35 pmRNSExchange Offer Final Results
11th Apr 20243:03 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
10th Apr 202411:49 amRNSExchange Offer Early Exchange Deadline Results
3rd Apr 20247:00 amRNSSatisfaction of employee share awards and TVR
28th Mar 20244:25 pmRNSExchange Offer for Outstanding Notes 2025 and 2026
28th Mar 202412:00 pmRNSCorrection - Scrip Dividend Share Reference Price
28th Mar 20247:00 amRNSScrip Dividend Share Reference Price
26th Mar 20249:41 amRNSBuy back of Shares into Treasury and TVR
22nd Mar 20244:06 pmRNSPublication of Annual Report and Date of AGM
12th Mar 20244:04 pmRNSInterim Dividend & Scrip Alternative
11th Mar 20243:48 pmRNSTransfer of shares out of treasury
11th Mar 20243:35 pmRNSPreliminary results FY23
11th Mar 20243:03 pmRNSSale of part of logistics portfolio
24th Nov 202312:34 pmRNSS&P - 'BB+' Rating affirmed
27th Sep 20237:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
19th Sep 20237:00 amRNSHalf-year Report
14th Sep 20237:00 amRNSScrip Dividend Share Reference Price
30th Aug 20237:00 amRNSInterim Dividend & Scrip Alternative
29th Aug 20233:43 pmRNSNotice of Interim Results & Prelim Interim Results
4th Jul 20237:00 amRNSInvestment grade rating maintained - Correction
3rd Jul 20236:19 pmRNSFitch investment grade credit rating maintained
27th Jun 20232:25 pmRNSResults of Tender Offers
20th Jun 20239:22 amRNSTender Offers Launch for 2025 Notes & 2026 Notes
19th Jun 202310:55 amRNSResult of AGM
8th Jun 20239:27 amRNSMoody's Ratings Action and Withdrawal
17th May 20237:00 amRNSAGM Notice & Availability of Annual Report
14th Apr 20233:52 pmRNSDirectorate Change
4th Apr 202312:33 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
31st Mar 20231:29 pmRNSBuy back of Shares into Treasury & TVR
24th Mar 20237:00 amRNSPosting of Annual Report and Date of AGM
23rd Mar 20237:00 amRNSScrip Dividend Share Reference Price
22nd Mar 20234:53 pmRNSS&P Rating Action
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20233:10 pmRNSInterim Dividend & Scrip Alternative
8th Mar 202312:12 pmRNSTransfer of Shares out of Treasury
8th Mar 202311:59 amRNSResult of EGM
3rd Mar 20237:00 amRNSCondensed Unaudited Results for FY 31 Dec 2022
24th Feb 20234:44 pmRNSNotice of EGM
23rd Dec 202210:30 amRNSNew Financing Facilities with the Erste Group
19th Dec 20227:00 amRNSCarbon Emissions Reduction Commitment
21st Oct 20223:00 pmRNSCEO succession
20th Sep 20227:00 amRNSHalf-year Report
16th Sep 20224:41 pmRNSSecond Price Monitoring Extn
16th Sep 20224:37 pmRNSPrice Monitoring Extension
31st Aug 20227:01 amRNSInterim Dividend Payment
31st Aug 20227:00 amRNSNotice of Interim Results & Prelim Interim Info
8th Jul 20227:00 amRNSStatement re stated post-offer intentions
21st Jun 202212:15 pmRNSRepayment of Bond
20th Jun 202210:36 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.